Federal Register / Vol. 79, No. 216 / Friday, November 7, 2014 / Notices 66371 

1 In particular, the written request for confidential 

treatment that accompanies the comment must 

include the factual and legal basis for the request, 

and must identify the specific portions of the 

Continued 

Consequently, notice is given that the 

receivership shall be terminated, to be 

effective no sooner than thirty days after 

the date of this Notice. If any person 

wishes to comment concerning the 

termination of the receivership, such 

comment must be made in writing and 

sent within thirty days of the date of 

this Notice to: Federal Deposit 

Insurance Corporation, Division of 

Resolutions and Receiverships, 

Attention: Receivership Oversight 

Department 34, 1601 Bryan Street, 

Dallas, TX 75201. 

No comments concerning the 

termination of this receivership will be 

considered which are not sent within 

this time frame. 

Dated: November 3, 2014. 

Federal Deposit Insurance Corporation. 

Robert E. Feldman, 

Executive Secretary. 

[FR Doc. 2014–26435 Filed 11–6–14; 8:45 am] 

BILLING CODE 6714–01–P 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies; 

Correction 

This notice corrects a notice (FR Doc. 

2014–26081) published on pages 65213 

and 65214 of the issue for Monday, 

November 3, 2014. 

Under the Federal Reserve Bank of 

Kansas City heading, the entry for Otten 

Holdings, LLC and FEO Investments, 

Inc., is revised to read as follows: 

A. Federal Reserve Bank of Kansas 

City (Dennis Denney, Assistant Vice 

President) 1 Memorial Drive, Kansas 

City, Missouri 64198–0001: 

1. Otten Holdings, LLC and FEO 

Investments, Inc., both in Norfolk, 

Nebraska; to acquire 100 percent of the 

voting shares of First National Agency, 

Inc., and thereby indirectly acquire First 

Nebraska Bank of Wayne, both in 

Wayne, Nebraska. 

Comments on this application must 

be received by November 28, 2014. 

Board of Governors of the Federal Reserve 

System, November 4, 2014. 

Michael J. Lewandowski, 

Associate Secretary of the Board. 

[FR Doc. 2014–26485 Filed 11–6–14; 8:45 am] 

BILLING CODE 6210–01–P 

FEDERAL TRADE COMMISSION 

[Docket No. 9360] 

Ferrellgas Partners, L.P.; Ferrellgas, 

L.P., Also Doing Business as Blue 

Rhino; AmeriGas Partners, L.P., Also 

Doing Business as AmeriGas Cylinder 

Exchange; and UGI Corporation; 

Analysis To Aid Public Comment 

AGENCY: Federal Trade Commission. 

ACTION: Proposed consent agreements. 

SUMMARY: The consent agreements in 

this matter settle alleged violations of 

federal law prohibiting unfair methods 

of competition. The attached Analysis to 

Aid Public Comment describes both the 

allegations in the administrative 

complaint issued by the Commission 

and the terms of the consent orders— 

embodied in the consent agreements— 

that would settle these allegations. 

DATES: Comments must be received on 

or before December 2, 2014. 

ADDRESSES: Interested parties may file a 

comment at https://

ftcpublic.commentworks.com/ftc/

amerigasbluerhinoconsent online or on 

paper, by following the instructions in 

the Request for Comment part of the 

SUPPLEMENTARY INFORMATION section 

below. Write ‘‘In the Matter of AmeriGas 

and Blue Rhino—Consent Agreement; 

Docket No. 9360’’ on your comment and 

file your comment online at https://

ftcpublic.commentworks.com/ftc/

amerigasbluerhinoconsent by following 

the instructions on the web-based form. 

If you prefer to file your comment on 

paper, write ‘‘In the Matter of AmeriGas 

and Blue Rhino—Consent Agreement; 

Docket No. 9360’’ on your comment and 

on the envelope, and mail it to the 

following address: Federal Trade 

Commission, Office of the Secretary, 

600 Pennsylvania Avenue NW., Suite 

CC–5610 (Annex D), Washington, DC 

20580, or deliver your comment to the 

following address: Federal Trade 

Commission, Office of the Secretary, 

Constitution Center, 400 7th Street SW., 

5th Floor, Suite 5610 (Annex D), 

Washington, DC 20024. 

FOR FURTHER INFORMATION CONTACT: Eric 

Edmondson, FTC Western Region, San 

Francisco, (415–848–5179), 901 Market 

Street, Suite 570, San Francisco, CA 

94103. 

SUPPLEMENTARY INFORMATION: Pursuant 

to Section 6(f) of the Federal Trade 

Commission Act, 15 U.S.C. 46(f), and 

FTC Rule 3.25(f), 16 CFR 3.25(f), notice 

is hereby given that the above-captioned 

consent agreements containing consent 

orders to cease and desist, having been 

filed with and accepted, subject to final 

approval, by the Commission, have been 

placed on the public record for a period 

of thirty (30) days. The following 

Analysis to Aid Public Comment 

describes the terms of the consent 

agreements, and the allegations in the 

complaint. An electronic copy of the 

full text of each consent agreement 

package can be obtained from the FTC 

Home Page (for October 31, 2014), on 

the World Wide Web, at http://

www.ftc.gov/os/actions.shtm. 

You can file a comment online or on 

paper. For the Commission to consider 

your comment, we must receive it on or 

before December 2, 2014. Write ‘‘In the 

Matter of AmeriGas and Blue Rhino— 

Consent Agreement; Docket No. 9360’’ 

on your comment. Your comment— 

including your name and your state— 

will be placed on the public record of 

this proceeding, including, to the extent 

practicable, on the public Commission 

Web site, at http://www.ftc.gov/os/

publiccomments.shtm. As a matter of 

discretion, the Commission tries to 

remove individuals’ home contact 

information from comments before 

placing them on the Commission Web 

site. 

Because your comment will be made 

public, you are solely responsible for 

making sure that your comment does 

not include any sensitive personal 

information, like anyone’s Social 

Security number, date of birth, driver’s 

license number or other state 

identification number or foreign country 

equivalent, passport number, financial 

account number, or credit or debit card 

number. You are also solely responsible 

for making sure that your comment does 

not include any sensitive health 

information, like medical records or 

other individually identifiable health 

information. In addition, do not include 

any ‘‘[t]rade secret or any commercial or 

financial information which . . . is 

privileged or confidential,’’ as discussed 

in Section 6(f) of the FTC Act, 15 U.S.C. 

46(f), and FTC Rule 4.10(a)(2), 16 CFR 

4.10(a)(2). In particular, do not include 

competitively sensitive information 

such as costs, sales statistics, 

inventories, formulas, patterns, devices, 

manufacturing processes, or customer 

names. 

If you want the Commission to give 

your comment confidential treatment, 

you must file it in paper form, with a 

request for confidential treatment, and 

you have to follow the procedure 

explained in FTC Rule 4.9(c), 16 CFR 

4.9(c).1 Your comment will be kept 

mstockstill on DSK4VPTVN1PROD with NOTICES